OrbiMed Advisors LLC Reduces Stake in TELA Bio Inc

Yahoo Finance09:05

Express News | Orbimed Advisors LLC Reports 4.8% Stake in TELA Bio as of October 23, 2024 Vs 8.6% Stake as of September 27, 2024 - SEC Filing

Breakings04:33

Insider Purchase: CEO, COO, CFO, and CTO of TELA Bio (TELA) Buy Shares

BarchartOct 25 15:02

Tela Bio Prices $40 Mln Public Offering At $2.25/share

RTTNewsOct 23 21:14

Piper Sandler Maintains TELA Bio(TELA.US) With Buy Rating, Maintains Target Price $8

Futu NewsOct 23 20:35 · Ratings

Express News | TELA Bio Inc - Prices Public Offering of 12 Mln Shares at $2.25 Each

BreakingsOct 23 20:07